SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-21-025625
Filing Date
2021-05-11
Accepted
2021-05-11 16:38:14
Documents
51
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2020a1_falconcapitalacq.htm 10-K/A 988312
2 CERTIFICATION f10k2020ex31-1_falconcapital.htm EX-31.1 7758
3 CERTIFICATION f10k2020ex31-2_falconcapital.htm EX-31.2 7790
4 CERTIFICATION f10k2020ex32-1_falconcapital.htm EX-32.1 3835
5 CERTIFICATION f10k2020ex32-2_falconcapital.htm EX-32.2 3738
  Complete submission text file 0001213900-21-025625.txt   3532160

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE fcac-20201231.xml EX-101.INS 454679
7 XBRL SCHEMA FILE fcac-20201231.xsd EX-101.SCH 42406
8 XBRL CALCULATION FILE fcac-20201231_cal.xml EX-101.CAL 18335
9 XBRL DEFINITION FILE fcac-20201231_def.xml EX-101.DEF 194167
10 XBRL LABEL FILE fcac-20201231_lab.xml EX-101.LAB 318623
11 XBRL PRESENTATION FILE fcac-20201231_pre.xml EX-101.PRE 199711
Mailing Address 660 MADISON AVENUE 12TH FLOOR NEW YORK NY 10065
Business Address 660 MADISON AVENUE 12TH FLOOR NEW YORK NY 10065 (212) 812-7702
Falcon Capital Acquisition Corp. (Filer) CIK: 0001816233 (see all company filings)

IRS No.: 851365053 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39535 | Film No.: 21911864
SIC: 8000 Services-Health Services
Office of Life Sciences